BR112021005097A2 - lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos - Google Patents

lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos Download PDF

Info

Publication number
BR112021005097A2
BR112021005097A2 BR112021005097-3A BR112021005097A BR112021005097A2 BR 112021005097 A2 BR112021005097 A2 BR 112021005097A2 BR 112021005097 A BR112021005097 A BR 112021005097A BR 112021005097 A2 BR112021005097 A2 BR 112021005097A2
Authority
BR
Brazil
Prior art keywords
composition
compositions
tear
poloxamer
present
Prior art date
Application number
BR112021005097-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Gerald Horn
Original Assignee
Ps Therapy Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/137,738 external-priority patent/US20190021990A1/en
Priority claimed from US16/372,625 external-priority patent/US11583496B2/en
Priority claimed from US16/372,596 external-priority patent/US20190225917A1/en
Priority claimed from US16/372,582 external-priority patent/US20190224136A1/en
Priority claimed from US16/412,943 external-priority patent/US20190262290A1/en
Application filed by Ps Therapy Ltd. filed Critical Ps Therapy Ltd.
Publication of BR112021005097A2 publication Critical patent/BR112021005097A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112021005097-3A 2018-09-21 2019-09-19 lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos BR112021005097A2 (pt)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US16/137,738 2018-09-21
US16/137,738 US20190021990A1 (en) 2016-10-12 2018-09-21 Artificial tear compositions and methods of use thereof
US16/372,625 US11583496B2 (en) 2016-10-12 2019-04-02 Drug vehicle compositions and methods of use thereof
US16/372,625 2019-04-02
US16/372,596 US20190225917A1 (en) 2016-10-12 2019-04-02 Contact lens compositions and methods of use thereof
US16/372,582 2019-04-02
US16/372,596 2019-04-02
US16/372,582 US20190224136A1 (en) 2016-10-12 2019-04-02 Artificial tear compositions and methods of use thereof
US16/412,943 US20190262290A1 (en) 2016-10-12 2019-05-15 Drug vehicle compositions and methods of use thereof
US16/412,943 2019-05-15
PCT/US2019/051825 WO2020061249A2 (fr) 2018-09-21 2019-09-19 Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation

Publications (1)

Publication Number Publication Date
BR112021005097A2 true BR112021005097A2 (pt) 2021-06-08

Family

ID=69887791

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021005097-3A BR112021005097A2 (pt) 2018-09-21 2019-09-19 lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos

Country Status (6)

Country Link
EP (1) EP3853317A4 (fr)
JP (1) JP2022511335A (fr)
CN (1) CN113227304A (fr)
BR (1) BR112021005097A2 (fr)
CA (1) CA3112278A1 (fr)
WO (1) WO2020061249A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220350163A1 (en) 2021-04-29 2022-11-03 Coopervision International Limited Ws12-releasing contact lens
CN115671256B (zh) * 2021-07-30 2024-04-09 四川大学华西医院 环孢素a与地夸磷索钠联合使用在制备治疗干眼症的药物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022131A1 (fr) * 2000-09-13 2002-03-21 Santen Pharmaceutical Co., Ltd. Collyre
JP5525816B2 (ja) * 2007-09-14 2014-06-18 ロート製薬株式会社 眼科用組成物
WO2011084473A1 (fr) * 2009-12-15 2011-07-14 Foresight Biotherapeutics, Inc. Compositions ophtalmiques anti-irritation à base de povidone iodée
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
US8597629B1 (en) * 2013-06-21 2013-12-03 Premium Ocular Solutions LLC. Artificial tear compositions comprising a combination of nonionic surfactants
PT3721868T (pt) * 2015-01-26 2022-08-12 Bausch & Lomb Composição para suspensão oftálmica
WO2016190306A1 (fr) * 2015-05-28 2016-12-01 ロート製薬株式会社 Composition ophtalmique aqueuse
EP4008311B1 (fr) * 2016-10-12 2023-09-13 PS Therapy, Inc. Larmes artificielles, lentilles de contact et compositions de véhicule pour médicament et leurs procédés d'utilisation

Also Published As

Publication number Publication date
CA3112278A1 (fr) 2020-03-26
JP2022511335A (ja) 2022-01-31
WO2020061249A2 (fr) 2020-03-26
EP3853317A2 (fr) 2021-07-28
EP3853317A4 (fr) 2022-06-22
WO2020061249A3 (fr) 2020-07-23
CN113227304A (zh) 2021-08-06

Similar Documents

Publication Publication Date Title
JP7432654B2 (ja) 人工涙液、コンタクトレンズ及び薬剤担体組成物並びにその使用方法
US11583496B2 (en) Drug vehicle compositions and methods of use thereof
CA2851398C (fr) Compositions pour le traitement de l'oeil sec
Lanier et al. Review of approaches for increasing ophthalmic bioavailability for eye drop formulations
US11260035B2 (en) Topical compositions and methods of use thereof
US20200009044A1 (en) Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
US20220080048A1 (en) Opthalmological compositions and methods of use thereof
JP2013534527A (ja) コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物
BR112021005097A2 (pt) lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos
US20190262290A1 (en) Drug vehicle compositions and methods of use thereof
Kymionis et al. Dry eye after photorefractive keratectomy with adjuvant mitomycin C
WO2021087051A1 (fr) Compositions topiques et leurs procédés d'utilisation
US20190021990A1 (en) Artificial tear compositions and methods of use thereof
US20220133626A1 (en) Topical compositions and methods of use thereof
US20200397727A1 (en) Drug vehicle compositions and methods of use thereof
US20230285286A1 (en) Drug vehicle compositions and methods of use thereof
US20230235247A1 (en) Contact lens compositions and methods of use thereof
US20190224136A1 (en) Artificial tear compositions and methods of use thereof
US20190225917A1 (en) Contact lens compositions and methods of use thereof
Akers et al. Practical Aspects of Ophthalmic Drug Devlopment
Jaanus Preparations for the Dry Eye
Saurabh Studies on in situ gelling system for better ocular drug therapy

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]